| Are the Protean Effects of Pentoxifylline in the Therapy of Diabetes and Its Complications Still Relevant? | Diabetes Therapy | 1 day | save |  |  |  |
| Glycaemic Control in People with Diabetes Starting Treatment with Fast-Acting Insulin Aspart: a US Database Study | Diabetes Therapy | 3 days | save | | | |
| Relationship Between Bedside Ketone Levels and Time to Resolution of Diabetic Ketoacidosis: A Retrospective Cohort Study | Diabetes Therapy | 5 days | save | | | |
| Impact of SARS-CoV-2 on Progression of Glycemic and Cardiometabolic Variables and Changes in Insulin Indices: A Longitudinal Study | Diabetes Therapy | 9 days | save | | | |
| The Value of Insulin Degludec in Frail Older Adults with Type 2 Diabetes | Diabetes Therapy | 10 days | save | | | |
| Effectiveness and Safety of Insulin Glargine 300 U/ml in Comparison with Insulin Degludec 100 U/ml Evaluated with Continuous Glucose Monitoring in Adults with Type 1 Diabetes and Suboptimal Glycemic Control in Routine Clinical Practice: The OneCARE S | Diabetes Therapy | 12 days | save | | | |
| An Update to the Article“Efficacy and Side Effect Profile of Different Formulations of Metformin: A Systematic Review and Meta-Analysis” | Diabetes Therapy | 13 days | save | | | |
| Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM | Diabetes Therapy | 15 days | save | | | |
| Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from the SURE UK Multicentre, Prospective, Observational Study | Diabetes Therapy | 17 days | save | | | |
| Correction to: Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study | Diabetes Therapy | 21 days | save | | | |
| A Review of Interventional Trials in Youth-Onset Type 2 Diabetes: Challenges and Opportunities | Diabetes Therapy | 22 days | save | | | |
| Satisfaction, Preference and Injection Habits of Switching to 200 Units/ml Insulin Lispro Pen from 100 Units/ml: A Patient Survey in Germany | Diabetes Therapy | 25 days | save | | | |
| Association of Acarbose with Decreased Muscle Mass and Function in Patients with Type 2 Diabetes: A Retrospective, Cross-Sectional Study | Diabetes Therapy | 25 days | save | | | |
| Efficacy and Safety of Switching to Teneligliptin in Patients with Type 2 Diabetes Inadequately Controlled with Dipeptidyl Peptidase-4 Inhibitors: 52-Week Results from a Prospective Observational Study | Diabetes Therapy | 27 days | save | | | |
| Immediate Glucose-Lowering Effect After the First Administration of Dulaglutide: A Retrospective, Single-Center, Observational Study | Diabetes Therapy | 28 days | save | | | |
| Correction to: Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory Trial | Diabetes Therapy | 32 days | save | | | |
| The Therapeutic Effects of Mild to Moderate Intensity Aerobic Exercise on Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Trials | Diabetes Therapy | 33 days | save | | | |
| The Association Between Mean Glycated Haemoglobin or Glycaemic Variability and the Development of Retinopathy in People with Diabetes: A Retrospective Observational Cohort Study | Diabetes Therapy | 38 days | save | | | |
| Effects of Different Glucose-Lowering Measures on Maternal and Infant Outcomes in Pregnant Women with Gestational Diabetes: A Network Meta-analysis | Diabetes Therapy | 40 days | save | | | |
| The Effect of Verapamil on TXNIP Gene Expression, GLP1R mRNA, FBS, HbA1c, and Lipid Profile in T2DM Patients Receiving Metformin and Sitagliptin | Diabetes Therapy | 41 days | save | | | |
| Identification of the Inappropriate Clinical Actions (DON'T) to Improve the Management of Patients with Type 2 Diabetes Failing Basal Insulin Supported Oral Treatment: Results of Survey for a Panel of Diabetes Specialists in Italy | Diabetes Therapy | 55 days | save | | | |
| Alcohol Consumption as a Causator and/or an Accelerator of Neuropathy in People With Diabetes Is Regularly Overlooked | Diabetes Therapy | 57 days | save | | | |
| Development of Exogenous Insulin Antibody Syndrome in a Patient with Newly Diagnosed Type 1 Diabetes Successfully Treated with Oral Immunosuppressive Monotherapy | Diabetes Therapy | 58 days | save | | | |
| Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study | Diabetes Therapy | 59 days | save | | | |
| The Challenge of Sustainable Access to Telemonitoring Tools for People with Diabetes in Europe: Lessons from COVID-19 and Beyond | Diabetes Therapy | 60 days | save | | | |
| Does Current Diabetes Technology Improve Metabolic Control? A Cross-Sectional Study on the Use of Insulin Pumps and Continuous Glucose Monitoring Devices in a Nationwide Pediatric Population | Diabetes Therapy | 60 days | save | | | |
| Effects of Moderate-Intensity Aerobic Exercise on Blood Glucose Levels and Pregnancy Outcomes in Patients With Gestational Diabetes Mellitus: A Randomized Controlled Trial | Diabetes Therapy | 60 days | save | | | |
| The Durability of an Intensive, Structured Education-Based Rehabilitation Protocol for Best Insulin Injection Practice: The ISTERP-2 Study | Diabetes Therapy | 64 days | save | | | |
| Efficacy of a New Protocol of Premixed 70/30 Human Insulin in Haitian Youth with Diabetes | Diabetes Therapy | 64 days | save | | | |
| Assessment of Patient Satisfaction with On-Site Point-of-Care Hemoglobin A1c Testing: An Observational Study | Diabetes Therapy | 68 days | save | | | |
| Correction to: Individualizing Time-in-Range Goals in Management of Diabetes Mellitus and Role of Insulin: Clinical Insights From a Multinational Panel | Diabetes Therapy | 68 days | save | | | |
| The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus | Diabetes Therapy | 70 days | save | | | |
| Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study | Diabetes Therapy | 71 days | save | | | |
| Does electrifying organic synthesis pay off? The energy efficiency of electro-organic conversions | Diabetes Therapy | 72 days | save | | | |
| Role of titanium carbide and alumina on the friction increment for Cu-based metallic brake pads under different initial braking speeds | Diabetes Therapy | 72 days | save | | | |
| Penetration and lubrication evaluation of vegetable oil with nanographite particles for broaching process | Diabetes Therapy | 72 days | save | | | |
| Fundamental study on chaotic transition of two-phase flow regime and free surface instability in gas deaeration process | Diabetes Therapy | 72 days | save | | | |
| Correction to: Thermal hydraulic considerations of nuclear reactor systems: Past, present and future challenges | Diabetes Therapy | 72 days | save | | | |
| An efficient three-dimensional foil structure model for bump-type gas foil bearings considering friction | Diabetes Therapy | 72 days | save | | | |
| A novel point source oxygen supply method for sleeping environment improvement at high altitudes | Diabetes Therapy | 72 days | save | | | |
| Thermal comfort in winter incorporating solar radiation effects at high altitudes and performance of improved passive solar design—Case of Lhasa | Diabetes Therapy | 72 days | save | | | |
| The effects of portable cooling systems on thermal comfort and work performance in a hot environment | Diabetes Therapy | 72 days | save | | | |
| Does laser surface texturing really have a negative impact on the fatigue lifetime of mechanical components? | Diabetes Therapy | 72 days | save | | | |
| Black phosphorus quantum dots: A new-type of water-based high-efficiency lubricant additive | Diabetes Therapy | 72 days | save | | | |
| Individual thermal comfort prediction using classification tree model based on physiological parameters and thermal history in winter | Diabetes Therapy | 72 days | save | | | |
| Correction to: From indoor exposure to inhaled particle deposition: A multiphase journey of inhaled particles | Diabetes Therapy | 72 days | save | | | |
| An exploration of frictional and vibrational behaviors of textured deep groove ball bearing in the vicinity of requisite minimum load | Diabetes Therapy | 72 days | save | | | |
| Improvement of the lubrication properties of grease with Mn3O4/graphene (Mn3O4#G) nanocomposite additive | Diabetes Therapy | 72 days | save | | | |
| A low-to-high friction transition in gradient nano-grained Cu and Cu-Ag alloys | Diabetes Therapy | 72 days | save | | | |
| Exploring the role of−NH2 functional groups of ethylenediamine in chemical mechanical polishing of GCr15 bearing steel | Diabetes Therapy | 72 days | save | | | |
| | 
report | next » |
| |
